Biosimilars

360iResearch predicts the global biosimilars market to grow from USD 6,738.15 million in 2018 to USD 31,872.68 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.86%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: April 15, 2019 | Pages: 159 | Price: $3999 Trending

360iResearch predicts the china biosimilars market to grow from USD 0.53 billion in 2017 to USD 7.12 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 44.83%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 75 | Price: $1499 Trending

360iResearch predicts the united states biosimilars market to grow from USD 855.47 million in 2018 to USD 3,808.85 million by 2025, at a Compound Annual Growth Rate (CAGR) of 23.78%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 64 | Price: $1499 Trending

360iResearch predicts the united kingdom biosimilars market to grow from USD 295.93 million in 2018 to USD 1,353.15 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.25%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 73 | Price: $1499 Trending

360iResearch predicts the united arab emirates biosimilars market to grow from USD 50.94 million in 2018 to USD 235.83 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.48%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 63 | Price: $1499 Trending

360iResearch predicts the thailand biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 79 | Price: $1499

360iResearch predicts the taiwan biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 63 | Price: $1499

360iResearch predicts the sweden biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 76 | Price: $1499

360iResearch predicts the spain biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 72 | Price: $1499

360iResearch predicts the south korea biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 60 | Price: $1499

360iResearch predicts the singapore biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 67 | Price: $1499

360iResearch predicts the saudi arabia biosimilars market to grow from USD 73.28 million in 2018 to USD 341.11 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.57%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 76 | Price: $1499

360iResearch predicts the russia biosimilars market to grow from USD 183.68 million in 2018 to USD 856.30 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.60%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 69 | Price: $1499

360iResearch predicts the norway biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 61 | Price: $1499

360iResearch predicts the mexico biosimilars market to grow from USD 109.19 million in 2018 to USD 512.57 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.72%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 67 | Price: $1499

360iResearch predicts the malaysia biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 76 | Price: $1499

360iResearch predicts the latvia biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 73 | Price: $1499

360iResearch predicts the japan biosimilars market to grow from USD 252.90 million in 2018 to USD 1,241.71 million by 2025, at a Compound Annual Growth Rate (CAGR) of 25.52%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 75 | Price: $1499

360iResearch predicts the italy biosimilars market to grow from USD 115.16 million in 2018 to USD 535.58 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.56%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Publishing Date: June 2019 | Pages: 71 | Price: $1499

360iResearch predicts the indonesia biosimilars market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

Publishing Date: June 2019 | Pages: 79 | Price: $1499